Showing 41-60 of 644 for: Cochrane Systematic Reviews > Respiratory 
- Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
Cochrane Systematic Reviews, 4-Jan-2015
Mycoplasma pneumoniae (M. pneumoniae) is widely recognised as an important cause of community-acquired lower respiratory tract infection (LRTI) in children. Pulmonary manifestations are typically tracheobronchitis or pneumonia but M. pneumoniae is also i
- Antibiotics for community‐acquired pneumonia in adult outpatients
Cochrane Systematic Reviews, 9-Oct-2014
Lower respiratory tract infection (LRTI) is the third leading cause of death worldwide and the first leading cause of death in low-income countries. Community-acquired pneumonia (CAP) is a common condition that causes a significant disease burden for the
- Antibiotics for community‐acquired pneumonia in children
Cochrane Systematic Reviews, 4-Jun-2013
Pneumonia caused by bacterial pathogens is the leading cause of mortality in children in low-income countries. Early administration of antibiotics improves outcomes.
- Antibiotics for exacerbations of asthma
Cochrane Systematic Reviews, 25-Jun-2018
Asthma is a chronic respiratory condition that affects over 300 million adults and children worldwide. It is characterised by wheeze, cough, chest tightness, and shortness of breath. Symptoms typically are intermittent and may worsen over a short time, le
- Antibiotics for exacerbations of chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 29-Oct-2018
Many patients with an exacerbation of chronic obstructive pulmonary disease (COPD) are treated with antibiotics. However, the value of antibiotics remains uncertain, as systematic reviews and clinical trials have shown conflicting results.
- Antibiotics for persistent nasal discharge (rhinosinusitis) in children
Cochrane Systematic Reviews, 12-Dec-2007
Nasal discharge (rhinosinusitis) is extremely common in children. It is the result of inflammation of the mucosa of the upper respiratory tract, and is usually due to either infection or allergy. Infections may be caused by bacteria.
- Antibiotics for preterm rupture of membranes
Cochrane Systematic Reviews, 2-Dec-2013
Premature birth carries substantial neonatal morbidity and mortality. Subclinical infection is associated with preterm rupture of membranes (PROM). Prophylactic maternal antibiotic therapy might lessen infectious morbidity and delay labour, but could supp
- Antibiotics for prolonged wet cough in children
Cochrane Systematic Reviews, 31-Jul-2018
Cough is a frequent symptom presenting to doctors. The most common cause of childhood chronic (greater than fours weeks' duration) wet cough is protracted bacterial bronchitis (PBB) in some settings, although other more serious causes can also present thi
- Antibiotics for the common cold and acute purulent rhinitis
Cochrane Systematic Reviews, 4-Jun-2013
It has long been believed that antibiotics have no role in the treatment of common colds yet they are often prescribed in the belief that they may prevent secondary bacterial infections.
- Antibiotics for treating community‐acquired pneumonia in people with sickle cell disease
Cochrane Systematic Reviews, 14-Nov-2016
As a consequence of their condition, people with sickle cell disease are at high risk of developing an acute infection of the pulmonary parenchyma called community-acquired pneumonia. Many different bacteria can cause this infection and antibiotic treatme
- Antibiotics for treatment of sore throat in children and adults
Cochrane Systematic Reviews, 9-Dec-2021
Sore throat is a common reason for people to present for medical care and to be prescribed antibiotics. Overuse of antibiotics in primary medicine is a concern, hence it is important to establish their efficacy in treating sore throat and preventing secon
- Antibiotics for ureaplasma in the vagina in pregnancy
Cochrane Systematic Reviews, 7-Sep-2011
Preterm birth is a significant perinatal problem contributing to perinatal morbidity and mortality. Heavy vaginal ureaplasma colonisation is suspected of playing a role in preterm birth and preterm rupture of the membranes. Antibiotics are used to treat i
- Antibiotics for whooping cough (pertussis)
Cochrane Systematic Reviews, 10-Feb-2013
Whooping cough is a highly contagious respiratory disease. Infants are at highest risk of severe disease and death. Erythromycin for 14 days is currently recommended for treatment and contact prophylaxis but its benefit is uncertain.
- Antibiotics to reduce post‐tonsillectomy morbidity
Cochrane Systematic Reviews, 12-Dec-2012
This is an update of a Cochrane Review first published in The Cochrane Library in Issue 2, 2008 and previously updated in 2010.
- Anticholinergic agents for chronic asthma in adults
Cochrane Systematic Reviews, 19-Jul-2004
Anticholinergic agents such as ipratropium bromide are sometimes used in the treatment of chronic asthma. They effect bronchodilation and have also been used in combination with ß2 -agonists in the management of chronic asthma.
- Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 20-Jan-2003
Inhaled bronchodilators form the mainstay of treatment for acute exacerbations of COPD. Two types of agent are used routinely, either singly or in combination: anticholinergic agents and beta2-sympathomimetic agonists.
- Anticholinergic drugs for wheeze in children under the age of two years
Cochrane Systematic Reviews, 20-Jul-2005
Wheeze in infancy and early childhood is common and appears to be increasing though the magnitude of any increase is unclear. Most wheezing episodes in infancy are precipitated by respiratory viral infections. Treatment of very young children with wheeze
- Anticholinergic therapy for acute asthma in children
Cochrane Systematic Reviews, 29-Feb-2012
Inhaled anticholinergics as single agent bronchodilators (or in combination with beta2-agonists) are one of the several medications available for the treatment of acute asthma in children.
- Anticholinergic therapy for bronchiectasis
Cochrane Systematic Reviews, 23-Apr-2001
Anticholinergic agents block bronchoconstriction mediated by the vagus nerve and may also dry up bronchial secretions. They are effective in obstructive airways disease and may be beneficial in bronchiectasis
- Anticholinergic therapy for chronic asthma in children over two years of age
Cochrane Systematic Reviews, 21-Jul-2003
In the intrinsic system of controlling airway calibre, the cholinergic (muscarinic) sympathetic nervous system has an important role. Anticholinergic, anti muscarinic bronchodilators such as ipratropium bromide are frequently used in the management of chi
